Kyle Brown

As pharma organizations accelerate their digital transformation, AI is reshaping how marketing content moves from concept to approval. The promise of faster creation and shorter MLR cycles is undeniable—but so are the challenges. How can we achieve speed without sacrificing scientific rigor or patient trust? How do we embed AI responsibly within regulatory frameworks?

• This executive panel brings together leading voices from across the industry to share lessons learned, emerging best practices, and the real-world balance between innovation and accountability.
• Examining real-world use cases where AI-assisted drafting and automated pre-checks have reduced cycle times and improved efficiency
• Learning how MLR teams are using AI to enhance collaboration, accuracy, and speed across cross-functional review processes.
• Exploring strategies for maintaining scientific precision, compliance integrity, and brand authenticity
• Understanding how proactive partnerships with compliance bodies are shaping the next generation of AI-guided review standards